openPR Logo
Press release

Radiopharmaceutical Market Analysis by Top Manufacturers, Regions, Type, Applications and Forecasts to 2022

04-12-2017 10:56 AM CET | Health & Medicine

Press release from: ReportsnReports

Radiopharmaceutical Market Analysis by Top Manufacturers,

Global Radiopharmaceutical Market report is a professional and in-depth study on the current state of the Radiopharmaceutical industry. The Global Radiopharmaceutical Market report analyses the current trends, drivers and inhibitors impacting the Radiopharmaceutical market.

Read Full report @ http://www.reportsnreports.com/reports/953087-global-radiopharmaceutical-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:

This report focuses on the Radiopharmaceutical in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Check for DISCOUNT on Report @ http://www.reportsnreports.com/contacts/discount.aspx?name=953087 OR Inquire for copy of Report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=953087

This Report Covers Market Segment by Manufacturers:

· Bayer

· Triad Isotopes

· Lantheus

· GE Healthcare

· Mallinckrodt

· Eli Lilly

· Bracco Imaging

· SIEMENS

· Navidea

· Nordion

· IBA Group

· Jubilant Pharma

Market Segment by Regions, regional analysis covers:

North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Get a copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=953087

Market Segment by Type,

· Diagnostic Radioisotopes

· Therapeutic Radioisotopes

Market Segment by Applications,

· Oncology

· Cardiology

· Other

There are 15 Chapters to deeply display the global Radiopharmaceutical market.

Chapter 1: Describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2: Analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;

Chapter 3: Display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4: Show the global market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9: Analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11: Show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12: In Chapter Eleven Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15: Describe Radiopharmaceutical sales channel, distributors, traders, dealers, appendix and data source.

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Ritesh Tiwari
Tel: +1-888-391-5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceutical Market Analysis by Top Manufacturers, Regions, Type, Applications and Forecasts to 2022 here

News-ID: 499855 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Radiopharmaceutical

Nuclear Medicine Market: Advancing Healthcare with Radiopharmaceutical Innovatio …
The Nuclear Medicine Market is undergoing a rapid transformation in 2025, driven by technological advancements, shifting consumer preferences, and an increased emphasis on sustainability. Companies are leveraging digital solutions, AI-driven analytics, and automation to enhance operational efficiency and improve customer experiences. This report provides an in-depth analysis of key market trends, growth drivers, competitive dynamics, and emerging opportunities. Unlock Insights with a Free Sample Report @ https://www.skyquestt.com/sample-request/nuclear-medicine-market Market Outlook and Growth
Radiopharmaceutical/Nuclear Medicine Market Size and Trends
The radiopharmaceutical/nuclear medicine market is poised for significant expansion in the coming years. With advancements in technology, increasing disease prevalence, and a growing emphasis on personalized medicine, the market presents lucrative opportunities for stakeholders. As the healthcare landscape evolves, the integration of innovative radiopharmaceuticals into clinical practice will continue to enhance diagnostic and therapeutic outcomes, ultimately improving patient care. The key players in the radiopharmaceutical/nuclear medicine market include Eckert & Ziegler,
Radiopharmaceutical Market 2021 | Detailed Report
Radiopharmaceutical Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Radiopharmaceutical Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4123322 The report provides a comprehensive analysis of company profiles listed below: - Bracco Imaging - Bayer - Mallinckrodt - Nordion - Triad Isotopes - Lantheus -
Impressive Trends and Future Scope of Radiopharmaceutical Market
Radiopharmaceutical Market: Introduction According to the report, the global radiopharmaceutical market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Some of the factors driving the radiopharmaceutical market are expansion activities of key radiopharma players; applications in clinical trials; and increase in aging population, pipeline assessment of new drugs, and disease indication mortality. Shutdown of some of the
Radiopharmaceutical Market Development Status and Outlook 2024
Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals. Read Report Overview for Radiopharmaceutical Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html According to the
Competition Landscape for Radiopharmaceutical Market Global Industry 2024
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024. Download Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213 Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological